FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3023916143> ?p ?o ?g. }

• W3023916143 endingPage "112040" @default.
• W3023916143 startingPage "112040" @default.
• W3023916143 abstract "Safe and efficient intracellular delivery of CRISPR/Cas9 is a key step for effective therapeutic genome editing in a wide range of diseases. This remains challenging due to multiple drawbacks of the currently available vehicles. Here we report that epithelial cell -derived microvesicles (MVs) function as safe and natural carriers for efficient delivery of CRISPR/Cas9 to treat cancer. In our study, compared to epithelial cell -derived MVs, cancer -derived MVs were quickly absorbed intracellularly by recipient cancer cells in vitro and showed selective accumulation in tumors of HepG2 xenografts in vivo, due to their cancer cell tropism dependent targeting. Surprisingly, synergistic anti-tumor effect of sgIQ 1.1 loaded Cas9MVs/HEK293 + sorafenib was better than sgIQ 1.1 + Cas9MVs/HepG2 + sorafenib in vitro. In addition, qPCR results showed that miR-21 and miR-181a expression were upregulated in HepG2 cells treated with cancer cell -derived MVs that might support the cancer progression. Further, treatment of HepG2 xenografts with sgIQ 1.1 loaded Cas9MVs/HEK293 showed enhanced anti-cancer effect than sgIQ 1.1 + Cas9MVs/HepG2. Therefore, we conclude that normal cells -derived MVs can act as better and safe natural delivery systems for cancer therapeutics in the future." @default.
• W3023916143 created "2020-05-13" @default.
• W3023916143 creator A5001962625 @default.
• W3023916143 creator A5002587926 @default.
• W3023916143 creator A5015401166 @default.
• W3023916143 creator A5029812230 @default.
• W3023916143 creator A5043650155 @default.
• W3023916143 creator A5082475350 @default.
• W3023916143 creator A5083427382 @default.
• W3023916143 creator A5086839571 @default.
• W3023916143 creator A5091702178 @default.
• W3023916143 date "2020-07-01" @default.
• W3023916143 modified "2023-10-16" @default.
• W3023916143 title "Epithelial cell -derived microvesicles: A safe delivery platform of CRISPR/Cas9 conferring synergistic anti-tumor effect with sorafenib" @default.
• W3023916143 cites W1553842589 @default.
• W3023916143 cites W1780086376 @default.
• W3023916143 cites W1993642022 @default.
• W3023916143 cites W1995159945 @default.
• W3023916143 cites W1998238577 @default.
• W3023916143 cites W2000093333 @default.
• W3023916143 cites W2018516624 @default.
• W3023916143 cites W2023812111 @default.
• W3023916143 cites W2036176224 @default.
• W3023916143 cites W2039705224 @default.
• W3023916143 cites W2040250419 @default.
• W3023916143 cites W2046967218 @default.
• W3023916143 cites W2085982536 @default.
• W3023916143 cites W2106768517 @default.
• W3023916143 cites W2107008239 @default.
• W3023916143 cites W2114204804 @default.
• W3023916143 cites W2118421998 @default.
• W3023916143 cites W2121354606 @default.
• W3023916143 cites W2121882633 @default.
• W3023916143 cites W2124713665 @default.
• W3023916143 cites W2128685572 @default.
• W3023916143 cites W2151028126 @default.
• W3023916143 cites W2168743245 @default.
• W3023916143 cites W2463957665 @default.
• W3023916143 cites W2511569157 @default.
• W3023916143 cites W2558389982 @default.
• W3023916143 cites W2754835295 @default.
• W3023916143 cites W2786514708 @default.
• W3023916143 cites W2788845781 @default.
• W3023916143 cites W2789976756 @default.
• W3023916143 cites W2801215256 @default.
• W3023916143 doi "https://doi.org/10.1016/j.yexcr.2020.112040" @default.
• W3023916143 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32380039" @default.
• W3023916143 hasPublicationYear "2020" @default.
• W3023916143 type Work @default.
• W3023916143 sameAs 3023916143 @default.
• W3023916143 citedByCount "25" @default.
• W3023916143 countsByYear W30239161432020 @default.
• W3023916143 countsByYear W30239161432021 @default.
• W3023916143 countsByYear W30239161432022 @default.
• W3023916143 countsByYear W30239161432023 @default.
• W3023916143 crossrefType "journal-article" @default.
• W3023916143 hasAuthorship W3023916143A5001962625 @default.
• W3023916143 hasAuthorship W3023916143A5002587926 @default.
• W3023916143 hasAuthorship W3023916143A5015401166 @default.
• W3023916143 hasAuthorship W3023916143A5029812230 @default.
• W3023916143 hasAuthorship W3023916143A5043650155 @default.
• W3023916143 hasAuthorship W3023916143A5082475350 @default.
• W3023916143 hasAuthorship W3023916143A5083427382 @default.
• W3023916143 hasAuthorship W3023916143A5086839571 @default.
• W3023916143 hasAuthorship W3023916143A5091702178 @default.
• W3023916143 hasConcept C104317684 @default.
• W3023916143 hasConcept C132455925 @default.
• W3023916143 hasConcept C145059251 @default.
• W3023916143 hasConcept C1491633281 @default.
• W3023916143 hasConcept C20518536 @default.
• W3023916143 hasConcept C2778019345 @default.
• W3023916143 hasConcept C2778695046 @default.
• W3023916143 hasConcept C502942594 @default.
• W3023916143 hasConcept C54355233 @default.
• W3023916143 hasConcept C70721500 @default.
• W3023916143 hasConcept C86803240 @default.
• W3023916143 hasConcept C95444343 @default.
• W3023916143 hasConcept C98108389 @default.
• W3023916143 hasConceptScore W3023916143C104317684 @default.
• W3023916143 hasConceptScore W3023916143C132455925 @default.
• W3023916143 hasConceptScore W3023916143C145059251 @default.
• W3023916143 hasConceptScore W3023916143C1491633281 @default.
• W3023916143 hasConceptScore W3023916143C20518536 @default.
• W3023916143 hasConceptScore W3023916143C2778019345 @default.
• W3023916143 hasConceptScore W3023916143C2778695046 @default.
• W3023916143 hasConceptScore W3023916143C502942594 @default.
• W3023916143 hasConceptScore W3023916143C54355233 @default.
• W3023916143 hasConceptScore W3023916143C70721500 @default.
• W3023916143 hasConceptScore W3023916143C86803240 @default.
• W3023916143 hasConceptScore W3023916143C95444343 @default.
• W3023916143 hasConceptScore W3023916143C98108389 @default.
• W3023916143 hasFunder F4320321001 @default.
• W3023916143 hasFunder F4320326180 @default.
• W3023916143 hasFunder F4320335787 @default.
• W3023916143 hasIssue "2" @default.
• W3023916143 hasLocation W30239161431 @default.
• W3023916143 hasOpenAccess W3023916143 @default.
• W3023916143 hasPrimaryLocation W30239161431 @default.

• next